Konrad Oexle

Konrad Oexle

Auto-generated profile, based on publicly available information

Konrad Oexle

Institute of Neurogenomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2001 in Cell
Verified
Journal Article
Closed access
YGYaoqin Gong
Yaoqin Gong
RSRoger B. Slee
Roger B. Slee
NFNaomi Fukai
Naomi Fukai
GRGeorges Rawadi
Georges Rawadi
Sergio Roman-RomanSergio Roman-Roman
Sergio Roman-Roman
MWMatthew L. Warman
Matthew L. Warman

10 February 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VVVirginie J M Verhoeven
Virginie J M Verhoeven
PHPirro G Hysi
Pirro G Hysi
RWRobert Wojciechowski
Robert Wojciechowski
QFQiao Fan
Qiao Fan
JGJeremy Guggenheim
Jeremy Guggenheim
CHChristopher J Hammond
Christopher J Hammond

1 October 1999 in Nature Genetics
Verified
Journal Article
Closed access
KNKristen J. Nowak
Kristen J. Nowak
DWDuangrurdee Wattanasirichaigoon
Duangrurdee Wattanasirichaigoon
HGHans H. Goebel
Hans H. Goebel
MWMatthew Wilce
Matthew Wilce
KPKatarina Pelin
Katarina Pelin
NLNigel George Laing
Nigel George Laing

7 January 2016 in Human Genetics
Verified
Journal Article
Open access
PDF file
JMJanine Meienberg
Janine Meienberg
RBRémy Bruggmann
Rémy Bruggmann
KOKonrad Oexle
Konrad Oexle
GMGabor Matyas
Gabor Matyas
Current clinical next-generation sequencing is done by using gene panels and exome analysis, both of which involve selective capturing of target regions. However, capturing has limitations in sufficiently covering coding exons, especially GC-rich regions. We compared whole exome sequencing (WES) with the most recent PCR-free whole genome sequencing (WGS), showing that only the latter is able to provide hitherto unprecedented complete coverage of the coding region of the genome. Thus, from a clinical/technical point of view, WGS is the better WES so that capturing is no longer necessary for the most comprehensive genomic testing of Mendelian disorders.

12 June 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
AHAnke Hammerschlag
Anke Hammerschlag
SSSven Stringer
Sven Stringer
CLChristiaan de Leeuw
Christiaan de Leeuw
SSSuzanne Sniekers
Suzanne Sniekers
ETErdogan Taskesen
Erdogan Taskesen
DPDanielle Posthuma
Danielle Posthuma
Danielle Posthuma and colleagues report a genome-wide association analysis for insomnia complaints in 113,006 individuals from the UK Biobank that identifies associations with variants near seven genes. They find evidence for sex-specific genetic architectures underlying genetic risk for insomnia and genetic correlations between insomnia complaints and psychiatric and metabolic traits. Persistent insomnia is among the most frequent complaints in general practice. To identify genetic factors for insomnia complaints, we performed a genome-wide association study (GWAS) and a genome-wide gene-based association study (GWGAS) in 113,006 individuals. We identify three loci and seven genes associated with insomnia complaints, with the associations for one locus and five genes supported by joint analysis with an independent sample (n = 7,565). Our top association (MEIS1, P < 5 × 10−8) has previously been implicated in restless legs syndrome (RLS). Additional analyses favor the hypothesis that MEIS1 exhibits pleiotropy for insomnia and RLS and show that the observed association with insomnia complaints cannot be explained only by the presence of an RLS subgroup within the cases. Sex-specific analyses suggest that there are different genetic architectures between the sexes in addition to shared genetic factors. We show substantial positive genetic correlation of insomnia complaints with internalizing personality traits and metabolic traits and negative correlation with subjective well-being and educational attainment. These findings provide new insight into the genetic architecture of insomnia.

29 October 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
BBBeben Benyamin
Beben Benyamin
TETõnu Esko
Tõnu Esko
JRJanina S. Ried
Janina S. Ried
ARAparna Radhakrishnan
Aparna Radhakrishnan
SVSita H. Vermeulen
Sita H. Vermeulen
JWJohn B. Whitfield
John B. Whitfield
Variation in body iron is associated with or causes diseases, including anaemia and iron overload. Here, we analyse genetic association data on biochemical markers of iron status from 11 European-population studies, with replication in eight additional cohorts (total up to 48,972 subjects). We find 11 genome-wide-significant (P<5 × 10−8) loci, some including known iron-related genes (HFE, SLC40A1, TF, TFR2, TFRC, TMPRSS6) and others novel (ABO, ARNTL, FADS2, NAT2, TEX14). SNPs at ARNTL, TF, and TFR2 affect iron markers in HFE C282Y homozygotes at risk for hemochromatosis. There is substantial overlap between our iron loci and loci affecting erythrocyte and lipid phenotypes. These results will facilitate investigation of the roles of iron in disease.